| Product Code: ETC7376018 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Grenada`s import shipments of non-alcoholic steatohepatitis (NASH) biomarkers saw significant growth in 2024, with top exporting countries including India, Saint Lucia, Barbados, Ireland, and Trinidad and Tobago. The Herfindahl-Hirschman Index (HHI) indicated a shift from high to moderate concentration in 2024, reflecting a more diversified market. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 4.45%, with a notable growth rate of 29.86% from 2023 to 2024, signaling a rapidly expanding market for NASH biomarkers in Grenada.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2022 & 2032F |
3.3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2022 & 2032F |
3.6 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Grenada |
4.2.2 Growing awareness about the importance of early detection and diagnosis of NASH |
4.2.3 Technological advancements in biomarker development for NASH |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in Grenada |
4.3.2 High cost associated with biomarker testing for NASH |
4.3.3 Lack of standardized guidelines for NASH diagnosis and treatment in Grenada |
5 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2022 - 2032F |
6.1.3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2022 - 2032F |
6.1.4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2022 - 2032F |
6.1.5 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2022 - 2032F |
6.1.6 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2022 - 2032F |
6.1.7 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.2.3 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2022 - 2032F |
6.2.4 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2022 - 2032F |
7 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of research studies conducted on NASH biomarkers in Grenada |
8.2 Adoption rate of NASH biomarker testing by healthcare providers in Grenada |
8.3 Rate of incorporation of NASH biomarkers in clinical practice in Grenada |
9 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2022 & 2032F |
9.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2025 |
10.2 Grenada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here